Serotonin and epilepsy

Journal of Neurochemistry

Volumn 100, Issue 4, 2007, Pages 857-873

  Bagdy, Gyorgy ^a,b   Kecskemeti, Valeria ^b   Riba, Pal ^b   Jakus, Rita ^a  

^a NATIONAL INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Animal model; Epilepsy; GABA; Glutamate; Selective serotonin reuptake inhibitor antidepressant; Serotonin receptor

Indexed keywords

5 HYDROXYTRYPTOPHAN; AMELTOLIDE; CARBAMAZEPINE; CITALOPRAM; FLUOXETINE; LAMOTRIGINE; NORFLUOXETINE; PHENOBARBITAL; PHENYTOIN; PINDOLOL; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VALPROIC ACID; VANOXERINE; ZONISAMIDE;

ABSENCE; AUDIOGENIC SEIZURE; CONVULSION; DEPOLARIZATION; DEPRESSION; DRUG POTENTIATION; ELECTROENCEPHALOGRAM; ELECTROSTIMULATION; EPILEPSY; EPILEPTOGENESIS; FOCAL EPILEPSY; GRAND MAL EPILEPSY; GRAND MAL SEIZURE; HUMAN; HYPERPOLARIZATION; IMAGING; KINDLING; MYOCLONUS EPILEPSY; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NERVE EXCITABILITY; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR BINDING; RECEPTOR BLOCKING; REVIEW; SEIZURE; SEROTONIN BRAIN LEVEL; SEROTONIN RELEASE; TEMPORAL LOBE EPILEPSY; TONIC CLONIC SEIZURE;

ANIMALS; EPILEPSY; HUMANS; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGENTS;

ANIMALIA; MUS;

EID: 33846837628     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04277.x     Document Type: Review

References (128)

1. Ahmad S., Fowler L. J. and Whitton P. S. (2005) Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids. Epilepsy Res. 63, 141-149.
2. 2C receptors: a behavioral analysis. Exp. Neurol. 154, 522-530.
3. Azmitia E. C. and Whitaker-Azmitia E. C. (1999) Development and adult plasticity of serotoninergic neurons and their target, in Serotonergic Neurons and 5-HT Receptors in the CNS (Baumgarten, H. G. and Göther, M., eds), pp. 1-39. Springer, New York.
4. Babb T. L., Carr E. and Crandall P. H. (1973) Analysis of extracellular firing patterns of deep temporal lobe structures in man. Electroencephalogr. Clin. Neurophysiol. 34, 247-257.
5. Barnes N. M. and Sharp T. (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38, 1083-1152.
6. Bercovici E., Cortez M. A., Wang X. and Snead O. C. 3rd (2006) Serotonin depletion attenuates AY-9944-mediated atypical absence seizures. Epilepsia 47, 240-246.
7. Boess F. G. and Martin I. L. (1994) Molecular biology of 5-HT receptors. Neuropharmacology 33, 275-317.
8. Bonnycastle D. D., Giarman N. J. and Paasonen M. K. (1957) Anticonvulsant compounds and 5-Hydroxytryptamine in rat brain. Br. J. Pharmacol. 12, 228-231.
9. Borowicz K. K., Stepien K. and Czuczwar S. J. (2006) Fluoxetine enhances the anticonvulsant effects of conventional anti-epileptic drugs in maximal electroshock seizures in mice. Pharmacol. Rep. 58, 83-90.
10. 7 receptor affinity and protection against sound-induced seizures in DBA/2J mice. Naunyn Schmiedebergs Arch. Pharmacol. 356, 820-826.
11. Bradley P. B., Engel G., Feniuk W., Fozard J. R., Humphrey P. P., Middlemiss D. N., Mylecharane E. J., Richardson B. P. and Saxena P. R. (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25, 563-576.
12. Bragin A., Engel J. Jr, Wilson C. L., Vizentin E. and Mathern G. W. (1999) Electrophysiologic analysis of a chronic seizure model after unilateral hippocampal KA injection. Epilepsia 40, 1210-1221.
13. 2C receptor mutant mice. Nat. Genet. 16, 387-390.
14. 1A receptors. Eur. J. Pharmacol. 336, 1-6.
15. Browning R. A., Hoffman W. E. and Simonton R. L. (1978) Changes in seizure susceptibility after intracerebral treatment with 5,7-dihydroxy- tryptamine: role of serotonergic neurones. Ann. N. Y. Acad. Sci. 305, 437-456.
16. Buterbaugh C. G. (1978) Effects of drugs modifying central serotonergic function on the response of extensor and non-extensor rats to maximal electroshock. Life Sci. 23, 2393-2904.
17. Buzsáki G., Bickford R. G., Armstrong D. M., Ponomareff G., Chen K. S., Ruiz R., Thal L. J. and Gage F. H. (1988) Electric activity in the neocortex of freely moving young and aged rats. Neuroscience 26, 735-744.
18. 7 receptor-mediated depolarisation in the anterodorsal thalamus I.-II. J. Pharmacol. Exp. Ther. 297, 395-409.
19. Choi J. S., Hahn S. J., Rhie D. J., Yoon S. H., Jo Y. H. and Kim M. S. (1999) Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv 1.3. J. Pharmacol. Exp. Ther. 291, 1-6.
20. 11C]methyl-L- tryptophan positron emission tomography. Ann. Neurol. 44, 858-866.
21. Clinckers R., Smolders I., Meurs A., Ebinger G. and Michotte Y. (2004a) Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors. J. Neurochem. 89, 834-843.
22. Clinckers R., Smolders I., Meurs A., Ebinger G. and Michotte Y. (2004b) Anticonvulsant action of GBR-12909 and citalopram against acute experimentally induced limbic seizures. Neuropharmacology 47, 1053-1061.
23. Coenen A. M., Drinkenburg W. H., Inoue M. and van Luijtelaar E. L. (1992) Genetic models of absence epilepsy, with emphasis on the WAG/Rij strain of rats. Epilepsy Res. 12, 75-86.
24. D'Ambrosio R., Fender J. S., Fairbanks J. P., Simon E. A., Born D. E., Doyle D. L. and Miller J. W. (2005) Progression from frontal-parietal to mesial-temporal epilepsy after fluid percussion injury in the rat. Brain 128, 174-188.
25. Dailey J. W., Reigel C. E., Mishra P. K. and Jobe P. C. (1989) Neurobiology of seizure predisposition in the genetically epilepsy-prone rat. Epilepsy Res. 3, 3-17.
26. Dailey J. W., Yan Q. S., Mishra P. K., Burger R. L. and Jobe P. C. (1992) Effects of fluoxetine on convulsions and brain serotonin as detected by microdialysis in genetically epilepsy-prone rats. J. Pharmacol. 260, 533-540.
27. Dailey J. W., Yan Q. S., Adams-Curtis L. E., Ryu J. R., Ko K. H., Mishra P. K. and Jobe P. C. (1996) Neurochemical correlates of anti-epileptic drugs in the genetically epilepsy-prone rat (GEPR). Life Sci. 58, 259-266.
28. Dailey J. W., Reith M. E., Yan Q. S., Li M. Y. and Jobe P. C. (1997) Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats: dose-response relationships. Neurosci. Lett. 227, 13-16.
29. Deák F., Lasztoczi B., Pacher P., Petheo G. L. and Valeria Kecskemeti and Spat A. (2000) Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells. Neuropharmacology 39, 1029-1036.
30. 18F]MPPF PET study in narcolepsy. Neuroimage 30, 341-348.
31. Destexhe A., Bal T., McCormick D. A. and Sejnowski T. J. (1996) Ionic mechanisms underlying synchronized oscillations and propagating waves in a model of ferret thalamic slices. J. Neurophysiol. 76, 2049-2070.
32. Drevets W. C., Frank E., Price J. C., Kupfer D. J., Holt D., Greer P. J., Huang Y., Gautier C. and Mathis C. (1999) PET imaging of serotonin 1A receptor binding in depression. Biol. Psychiatry 46, 1375-1387.
33. Dube C., Richichi C., Bender R. A., Chung G., Litt B. and Baram T. Z. (2006) Temporal lobe epilepsy after experimental prolonged febrile seizures: prospective analysis. Brain 129, 911-922.
34. Engel J. Jr (2004) Models of focal epilepsy, in Advances in Clinical Neurophysiology (Hallett, M., Phillips, L., H. Schomer, D. L. II, and Massey, J. M., eds). Clin. Neurophysiol. 57, 392-399.
35. Filakovszky J. Gerber K. and Bagdy G. (1999) A serotonin-1A receptor agonist and N-methyl-D-aspartate receptor antagonist oppose each others effects in a genetic rat epilepsy model. Neurosci. Lett. 261, 89-92.
36. Filakovszky J. Kantor S. Halasz P. and Bagdy G. (2001) 8-OH-DPAT and MK-801 affect epileptic activity independently of vigilance. Neurochem. Int. 38, 551-556.
37. 2 receptors are enriched on neocortical pyramidal neurones destroyed by intrastriatal volkensin. J. Pharmacol. Exp. Ther. 261, 1273-1281.
38. 1A receptors in the dorsal hippocampus and inhibition of limbic seizures induced by kainic acid in rats. Br. J. Pharmacol. 119, 813-818.
39. 1A agonist 8-OH-DPAT increases the number of spike-wave discharges in a genetic rat model of absence epilepsy. Brain Res. 807, 243-245.
40. Giaretta D. Avoli M. and Gloor P. (1987) Intracellular recordings in pericruciate neurons during spike and wave discharges of feline generalized penicillin epilepsy. Brain Res. 405, 68-79.
41. Gloor P. (1978) Generalized epilepsy with bilateral synchronous spike and wave discharge. New findings concerning its physiological mechanisms. Electroencephalogr. Clin. Neurophysiol. Suppl. 34, 245-249.
42. Goddard G. V. McIntyre D. C. and Leech C. K. (1969) A permanent change in brain function resulting from daily electrical stimulation. Exp. Neurol. 25, 295-330.
43. Gould E. (1999) Serotonin and hippocampal neurogenesis. Neuropsychopharmacology 21, 46S-51S.
44. 7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsy. Neurosci. Lett. 359, 45-48.
45. 3 antagonist MDL-72222 exacerbates ethanol withdrawal seizures in mice. Alcohol Clin. Exp. Res. 18, 410-414.
46. 7 receptor in rat brain. Br. J. Pharmacol. 117, 657-666.
47. 1A receptors in mediating 5-Hydroxytryptophan induced myoclonic jerks in guinea pigs. Eur. J. Pharmacol. 294, 743-751.
48. Halász P., Filakovszky J. and Bagdy G. (2001) Sleep and epilepsy: A role of nitric oxide? Epilepsia 42, 573-574.
49. Halász P. Filakovszky J. Vargha A. and Bagdy G. (2002) Spike-wave discharge and the microstructure of sleep-wake continuum in idiopathic generalised epilepsy manifestations of generalized epilepsy with spike-wave pattern. Neurophysiol. Clin. 32, 38-53.
50. Hernandez E. J. Williams P. A. and Dudek P. A. (2002) Effects of fluoxetine and TFMPP on spontaneous seizures in rats with pilocarpine-induced epilepsy. Epilepsia 43, 1337-1345.
51. Hiramatsu M. K. Kawanaga K. Kabuto H. and Mori A. (1987) Reduced uptake and release of 5-Hydroxytryptamine and taurine in the cerebral cortex of epileptic El mice. Epilepsy Res. 1, 40-44.
52. Holmes G. L. (2004) Models for generalized seizures, in Advances in Clinical Neurophysiology (Hallett, M. Phillips, L. H. Schomer, D. L. II and Massey, J. M., eds). Clin. Neurophysiol. 57, 415-438.
53. Hoyer D. and Middlemiss D. N. (1989) Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends Pharmacol. Sci. 10, 130-132.
54. Hoyer D. Clarke D. E. Fozrd J. R. Harting P. R. Mylecharane E. J. Saxena P. R. and Humpherey P. P. A. (1994) VII. International Union of Pharmacology classification of receptors for 5-Hydroxytryptamine (serotonin). Pharmacol. Rev. 46, 157-203.
55. 2C receptors as a potential therapeutic target for the design of anti-epileptic drugs. Curr. Top. Med. Chem. 5, 59-64.
56. 2 receptor subtype specific drugs. Eur. J. Pharmacol. 282, 39-55.
57. 1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsy. Exp. Neurol. 182, 964-972.
58. Jakus R. Graf M. Ando R. D. Balogh B. Gacsalyi I. Levay G. Kantor S. and Bagdy G. (2004) Effects of two non-competitive AMPA receptor antagonists GYKI 52466 and GYKI 53405 on vigilance, behaviour and spike-wave discharges in a genetic rat model of absence epilepsy. Brain Res. 1008, 236-244.
59. Jobe P. C. Picchioni A. L. and Chin L. (1973) Role of brain 5-Hydroxytryptamine in audiogenic seizure in the rat. Life Sci. 13, 1-13.
60. Jobe P. C. Dailey J. W. and Wernicke J. F. (1999) A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. Crit. Rev. Neurobiol. 13, 317-356.
61. Juhasz C. Chugani D. C. Muzik O. Shah A. Asano E. Mangner T. J. Chakraborty P. K. Sood S. and Chugani H. T. (2003) α-Methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy. Neurology 60, 960-968.
62. B receptor antagonists and their interaction in rats with a genetic form of absence epilepsy. Eur. J. Pharmacol. 430, 251-259.
63. 2+ channel blocking potencies. Brain Res. Bull. 67, 112-132.
64. Kharatishvili I. Nissinen J. P. McIntosh T. K. and Pitkanen A. (2006) A model of post-traumatic epilepsy induced by lateral fluid-percussion brain injury in rats. Neuroscience 140, 685-697.
65. Kilian M. and Frey H. H. (1973) Central monoamines and convulsive thresholds in mice and rats. Neuropharmacology 12, 681-692.
66. Kullmann D. M. Asztely F. and Walker M. C. (2000) The role of mammalian ionotropic receptors in synaptic plasticity: LTP, LTD and epilepsy. Cell Mol. Life Sci. 57, 1551-1561.
67. Leander J. D. (1992) Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine, and ameltolide (LY201116). Epilepsia 33, 573-576.
68. Löscher W. (1984) Genetic animal models of epilepsy as a unique resource for the evaluation of anticonvulsant drugs. A review. Meth. Find. Exp. Clin. Pharmacol. 6, 531-547.
69. Löscher W. (2002) Animal models of epilepsy for the development of anti-epileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res. 50, 105-123.
70. Löscher W. and Schmidt D. (1988) Which animal models should be used in the search for new anti-epileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 2, 145-181.
71. Löscher W. Annies R. and Hönack D. (1991) The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats. Neurosci. Lett. 128, 191-194.
72. Magyar J. Rusznak Z. Harasztosi C. et al. (2003) Differential effects of fluoxetine enantiomers in mammalian neural and cardiac tissues. Int. J. Mol. Med. 11, 535-542.
73. Mamounas L. A., Altar C. A., Blue M. E., Kaplan D. R., Tessarollo L. and Lyons W. E. (2000) BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J. Neurosci. 20, 771-782.
74. Manning J. P. A., Richards D. A. and Bowery N. G. (2003) Pharmacology of absence epilepsy. Trends Pharmacol. Sci. 24, 542-549.
75. Matsumoto H. and Ajmone-Marsan C. (1964) Cellular mechanisms in experimental seizures. Science 144, 193-194.
76. Mazarati A. M., Baldwin R. A., Shinmei S. and Sankar R. (2005) In vivo interaction between serotonin and galanin receptors types 1 and 2 in the dorsal raphe: implication for limbic seizures. J. Neurochem. 95, 1495-1503.
77. McCormick D. A. (1992) Neurotransmitter actions in the thalamus and cerebral cortex. J. Clin. Neurophysiol. 9, 212-223.
78. McCormick D. A. and Wang Z. (1991) Serotonin and noradrenaline excite GABAergic neurones of guinea-pig and cat nucleus reticularis thalami. J. Physiol. 442, 235-255.
79. McNamara J. O. (1994) Cellular and molecular basis of epilepsy. J. Neurosci. 14, 3413-3425.
80. 18F]MPPF-PET study. Brain 127, 900-913.
81. 1 recognition site. Eur. J. Pharmacol. 90, 151-153.
82. Morimoto K., Fahnestock M. and Racine R. J. (2004) Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog. Neurobiol. 73, 1-60.
83. 11C] Methyl-L-tryptophan and glucose metabolism in patients with temporal lobe epilepsy. Neurology 60, 756-761.
84. O'Dell L. E., Li R., George F. R. and Ritz M. C. (2000) Molecular serotonergic mechanisms appear to mediate genetic sensitivity to cocaine-induced convulsions. Brain Res. 863, 213-224.
85. 2+-dependent dopamine release. Epilepsy Res. 13, 113-119.
86. + channels by antidepressant drugs. J. Pharmacol. Exp. Ther. 284, 208-214.
87. Pape H. C. and McCormick D. A. (1989) Noradrenaline and serotonin selectively modulate thalamic burst firing by enhancing a hyperpolarisation- activated cation current. Nature 340, 715-718.
88. 1A receptor mutant mice exhibit enhanced tonic, stress-induced and fluoxetine-induced serotonergic neurotransmission. J. Neurochem. 77, 607-617.
89. Pasini A., Tortorella A. and Gale K. (1992) Anticonvulsant effect of intranigral fluoxetine. Brain Res. 593, 287-290.
90. Pasini A., Tortorella A. and Gale K. (1996) The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin. Brain Res. 724, 84-88.
91. 1A receptors increases the seizure threshold for picrotoxin in mice. Eur. J. Pharmacol. 527, 105-110.
92. 3 receptors. Trends Pharmacol. Sci. 13, 391-397.
93. Pranzatelli M. R., Tate E., Huang Y., Haas R. H., Bodensteiner J., Ashwal S. and Franz D. (1995) Neuropharmacology of progressive myoclonus epilepsy: response to 5-Hydroxy-L-tryptophan. Epilepsia 36, 783-791.
94. Prendiville S. and Gale K. (1993) Anticonvulsant effect of systemic fluoxetine on focally-evoked limbic motor seizures in rats. Epilepsia 34, 381-384.
95. Przegalinski E. (1985) Monoamines and the pathophysiology of seizure disorders, in Handbook of Experimental Pharmacology (Frey, H. H. and Janz, D., eds), pp. 101-137. Springer-Verlag, Berlin.
96. Przegalinski E., Baran L. and Siwanowicz J. (1994) Role of 5-Hydroxytryptamine receptor subtypes in the 1-[3-(trifluoromethyl) phenyl] piperazine-induced increase in threshold for maximal electroconvulsions in mice. Epilepsia 35, 889-894.
97. Raju S. S., Noor A. R., Gurthu S., Giriyappanavar C. R., Acharya S. B., Low H. C. and Quah S. H. (1999) Effect of fluoxetine on maximal electroshock seizures in mice: acute vs chronic administration. Pharmacol. Res. 39, 451-454.
98. Salgado D. and Alkadhi K. A. (1995) Inhibition of epileptiform activity by serotonin in rat CA1 neurons. Brain Res. 669, 176-182.
99. Sarnyai Z., Sibille E. L., Pavlides C., Fenster R. J., McEwen B. S. and Toth M. (2000) Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin 1A receptors. Proc. Natl Acad. Sci. USA 97, 14 731-14 736.
100. 1A receptor binding in human temporal lobe epilepsy. Neurology 62, 1343-1351.
101. Schlicker E., Fink K., Zentner J. and Gothert M. (1996) Presynaptic inhibitory serotonin autoreceptors in the human hippocampus. Naunyn Schmiedebergs Arch. Pharmacol. 354, 393-396.
102. Semenova T. P. and Ticku M. K. (1992) Effects of 5-HT receptor antagonists on seizure susceptibility and locomotor activity in DBA/2 mice. Brain Res. 588, 229-236.
103. 2 receptors in interneurons. Synapse 9, 208-218.
104. Shouse M. N., Sterman M. B., Hauri P. J. and Belsito O. (1984) Sleep disruption with basal forebrain lesions decreases latency to amygdala kindling in cats. Electroencephalogr. Clin. Neurophysiol. 58, 369-377.
105. SneadO. C. 3rd (1995) Basic mechanisms of generalized absence seizures. Ann. Neurol. 37, 146-157.
106. Statnick M. A., Maring-Smith M. L., Clough R. W., Wang C., Dailey J. W., Jobe P. C. and Browning R. A. (1996) Effects of 5,7-dihydroxy-tryptamine on audiogenic seizures in genetically epilepsyprone rats. Life Sci. 59, 1763-1771.
107. 7 receptor mRNA in rat brain. Br. J. Pharmacol. 123, 229.
108. 2C serotonin receptors. Nature 374, 542-546.
109. Theodore W. H. (2003) Does serotonin play a role in epilepsy? Epilepsy Curr. 3, 173-177.
110. Theodore W. H., Giovacchini G., Bonwetsch R., Bagic A., Reeves-Tyer P., Herscovitch P. and Carson R. E. (2006) The effect of antiepileptic drugs on 5-HT-receptor binding measured by positron emission tomography. Epilepsia 47, 499-503.
111. 7 receptors in guinea pig brain. Br. J. Pharmacol. 115, 107-116.
112. 1A receptor binding in patients with temporal lobe epilepsy. Neurology 60, 749-756.
113. Trottier S., Evrard B., Vignal J. P., Scarabin J. M. and Chauvel P. (1996) The serotonergic innervation of the cerebral cortex in man and its changes in focal cortical dysplasia. Epilepsy Res. 25, 79-106.
114. Tytgat J., Maertens C. and Daenens P. (1997) Effect of fluoxetine on a neuronal, voltage-dependent potassium channel (Kv1.1). Br. J. Pharmacol. 122, 1417-1424.
115. 2B receptors in regulating generalised seizure threshold in rodents. Eur. J. Pharmacol. 359, 33-40.
116. Van Luijtelaar E. L., Drinkenburg W. H., van Rijn C. M. and Coenen A. M. (2002) Rat models of genetic absence epilepsy: what do EEG spike-wave discharges tell us about drug effects? Meth. Find. Exp. Clin. Pharmacol. 24, 65-70.
117. Van Wijngaarden I., Tulp M. T. and Soudijn W. (1990) The concept of selectivity in 5-HT receptor research. Eur. J. Pharmacol. 188, 301-312.
118. 7 receptors: current knowledge and future prospects. Trends Pharmacol. Sci. 21, 70-77.
119. Velasco M., Velasco F., Velasco A. L., Jimenez F., Brito F. and Marquez I. (2000) Acute and chronic electrical stimulation of the centromedian thalamic nucleus: modulation of reticulo-cortical systems and predictor factors for generalized seizure control. Arch. Med. Res. 31, 304-315.
120. Wada Y., Nakamura M., Hasegawa H. and Yamaguchi N. (1993) Intra-hippocampal injection of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) inhibits partial and generalized seizures induced by kindling stimulation in cats. Neurosci. Lett. 159, 179-182.
121. Wada Y., Shiraishi J., Nakamura M. and Hasegawa H. (1995) Prolonged but not acute fluoxetine administration produces its inhibitory effect on hippocampal seizures in rats. Psychopharmacology (Berl.) 118, 305-309.
122. Wada Y., Shiraishi J., Nakamura M. and Koshino Y. (1996) Biphasic action of the histamine precursor L-histidine in the rat kindling model of epilepsy. Neurosci. Lett. 204, 205-208.
123. Wada Y., Shiraishi J., Nakamura M. and Koshino Y. (1997) Role of serotonin receptor subtypes in the development of amygdaloid kindling in rats. Brain Res. 747, 338-342.
124. Wada Y., Hirao N., Shiraishi J., Nakamura M. and Koshino Y. (1999) Pindolol potentiates the effect of fluoxetine on hippocampal seizures in rats. Neurosci. Lett. 267, 61-64.
125. Ward A. A. Jr (1972) Topical convulsant metals, in Experimental Models of Epilepsy: a Manual for the Laboratory Worker (Purpura, D. P., Penry, J. K., Tower, D. B., Woodbury, D. M. and Walter, R. D., eds), pp. 13-35. Raven Press, New York.
126. Watanabe K., Ashby C. R. Jr, Katsumori H. and Minabe Y. (2000) The effect of the acute administration of various selective 5-HT receptor antagonists on focal hippocampal seizures in freely-moving rats. Eur. J. Pharmacol. 398, 239-246.
127. Welsh J. P., Placantonakis D. G., Warsetsky S. I., Marquez R. G., Bernstein L. and Aicher S. A. (2002) The serotonin hypothesis of myoclonus from the perspective of neuronal rhythmicity. Adv. Neurol. 89, 307-329.
128. Yan Q. S., Jobe P. C., Cheong J. H., Ko K. H. and Dailey J. W. (1994) Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy prone rats. Naunyn-Schmiedebergs Arch. Pharmacol. 350, 149-152.